Rheumatoid Arthritis Clinical Trials in San Antonio

Showing 661-680 of 1,334 trials

Quetiapine Augmentation of PE Therapy for the Treatment of Co-occurring PTSD and Mild Traumatic Brain Injury

NCT04280965

A pilot study to evaluate feasibility for a full-scale merit application. Specifically, for veterans considering prolonged exposure (PE) therapy, following the model established by Foa et al, we need to establish safety, and feasibility of quetiapine compared to treatment as usual (TAU) which employs multiple medications commonly used for PTSD in the VA system.

Post Traumatic Stress Disorder

The University of Texas Health Science Center at San Antonio28 participantsStarted Feb 2019

San Antonio, Texas, United States

COMPLETEDPHASE2< 1 mile

Evaluate the Efficacy and Safety of ACP-044 for the Treatment of Acute Postoperative Pain Following Bunionectomy

NCT04855240

To evaluate the efficacy of ACP-044 compared with placebo in the treatment of acute postoperative pain

Acute Postoperative PainBunionectomy

ACADIA Pharmaceuticals Inc.239 participantsStarted Mar 2021

Anaheim, California, United States • Pasadena, Maryland, United States • San Antonio, Texas, United States +1 more locations

COMPLETEDPHASE2< 1 mile

FX-322 in Adults With Stable Sensorineural Hearing Loss

NCT04120116

This is a phase 2a single and repeat dose exploratory efficacy study of intratympanic FX-322 compared to placebo in healthy male and female adults with stable sensorineural hearing loss.

Sensorineural Hearing LossNoise Induced Hearing LossSudden Sensorineural Hearing Loss

Frequency Therapeutics95 participantsStarted Oct 2019

Fresno, California, United States • Torrance, California, United States • Colorado Springs, Colorado, United States +13 more locations

Quetiapine Augmentation of PE Therapy for the Treatment of Co-occurring PTSD and Mild Traumatic Brain Injury

Evaluate the Efficacy and Safety of ACP-044 for the Treatment of Acute Postoperative Pain Following Bunionectomy

FX-322 in Adults With Stable Sensorineural Hearing Loss

Rheumatoid Arthritis Trials in Other Cities

First in Human Safety Study of FX-345 in Adults With Sensorineural Hearing Loss

Safety, Tolerability, and Pharmacokinetics of CAL056 Mesylate in Patients With Resistant or Refractory Solid Tumors

A Safety and Efficacy Study of XERMELO® + First-line Chemotherapy in Patients With Advanced Biliary Tract Cancer

Multi-Center Trial Utilizing Low Frequency Ultrasound in the Prevention of Post-Contrast Acute Kidney Injury

Tavilermide Ophthalmic Solution for the Treatment of Dry Eye

MK-7625A Versus Meropenem in Pediatric Participants With Complicated Urinary Tract Infection (cUTI) (MK-7625A-034)

Phase III Trial With Caplacizumab in Patients With Acquired Thrombotic Thrombocytopenic Purpura

A Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors

Antenatal Late Preterm Steroids (ALPS): A Randomized Placebo-Controlled Trial

(EXPLORER) Study of BLU-285 in Patients With Advanced Systemic Mastocytosis (AdvSM) and Relapsed or Refractory Myeloid Malignancies

Neoadjuvant Carboplatin and Vincristine and Standard Local Ophthalmic Therapy in Treating Patients With Intraocular Retinoblastoma

Effects of Oral Levosimendan on Respiratory Function in Patients With Amyotrophic Lateral Sclerosis (ALS): Open-Label Extension

Relative Bioavailability of LY03010 Compared to Listed Drug

Comparison of Sleep Apnea Assessment Strategies to Maximize TBI Rehabilitation Participation and Outcome

Study to Assess Efficacy and Safety of Inhaled Interferon-β Therapy for COVID-19

Assessment of Safety and Efficacy of Nerivio for the Migraine Prevention

Placebo-controlled, Single and Multiple Dose Study in Healthy Volunteers and Refractory Chronic Cough Patients to Assess the Safety, Tolerability, and Pharmacokinetics of Two Formulations of NTX-1175

Other Conditions in San Antonio